Bispham Barbara Harlin
See Remarks
Bispham Barbara Harlin has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Bispham Barbara Harlin is listed as See Remarks at CRESCENT BIOPHARMA, INC. Inside the rolling window, Bispham Barbara Harlin reported no open-market purchases and 2 open-market sales totaling $33K in CBIO. The largest disclosed transaction in the window is a sale of 1,218 CBIO shares on Jun 22, 2026, worth $22K.
Companies traded
Other insiders at CBIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$33K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bispham Barbara Harlin made?
Bispham Barbara Harlin has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Bispham Barbara Harlin trade?
Bispham Barbara Harlin has filed SEC Form 4 disclosures for 1 company, including CBIO.
When was Bispham Barbara Harlin's most recent SEC Form 4 filing?
Bispham Barbara Harlin's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Bispham Barbara Harlin's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bispham Barbara Harlin is listed as See Remarks.
What is Bispham Barbara Harlin's total buy and sell value in the current window?
Inside the rolling retention window, Bispham Barbara Harlin bought $0 and sold $33K based on SEC Form 4 filings.
What was Bispham Barbara Harlin's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,218 CBIO shares on 2026-06-22, worth $22K, per SEC Form 4 filings.